ID   ANRA2_HUMAN             Reviewed;         313 AA.
AC   Q9H9E1;
DT   10-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   07-APR-2021, entry version 159.
DE   RecName: Full=Ankyrin repeat family A protein 2;
DE   AltName: Full=RFXANK-like protein 2;
GN   Name=ANKRA2; Synonyms=ANKRA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11095640;
RA   Rader K., Orlando R.A., Lou X., Farquhar M.G.;
RT   "Characterization of ANKRA, a novel ankyrin repeat protein that interacts
RT   with the cytoplasmic domain of megalin.";
RL   J. Am. Soc. Nephrol. 11:2167-2178(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Mao Y., Xie Y., Zhou Z., Zhao W., Zhao S., Wang W., Huang Y., Wang S.,
RA   Tang R., Chen X., Wu C.;
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH NEK6.
RX   PubMed=20873783; DOI=10.1021/pr100562w;
RA   Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C., Santana Bernachi J.,
RA   Paes Leme A.F., Kobarg J.;
RT   "Characterization of hNek6 interactome reveals an important role for its
RT   short N-terminal domain and colocalization with proteins at the
RT   centrosome.";
RL   J. Proteome Res. 9:6298-6316(2010).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.57 ANGSTROMS) OF 148-313 IN COMPLEX WITH HDAC4 AND
RP   LRP2 PEPTIDES, DOMAIN ANK REPEATS, INTERACTION WITH LRP2; HDAC4 AND HDAC5,
RP   AND MUTAGENESIS OF TRP-188 AND TYR-254.
RX   PubMed=22649097; DOI=10.1126/scisignal.2002979;
RA   Xu C., Jin J., Bian C., Lam R., Tian R., Weist R., You L., Nie J.,
RA   Bochkarev A., Tempel W., Tan C.S., Wasney G.A., Vedadi M., Gish G.D.,
RA   Arrowsmith C.H., Pawson T., Yang X.J., Min J.;
RT   "Sequence-specific recognition of a PxLPxI/L motif by an ankyrin repeat
RT   tumbler lock.";
RL   Sci. Signal. 5:RA39-RA39(2012).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 142-313 IN COMPLEX WITH CCDC8,
RP   X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) OF 142-313 IN COMPLEX WITH RFX7,
RP   FUNCTION, INTERACTION WITH RFX7 AND THE 3M COMPLEX, DOMAIN, AND MUTAGENESIS
RP   OF LYS-31 AND TRP-188.
RX   PubMed=25752541; DOI=10.1016/j.str.2015.02.001;
RA   Nie J., Xu C., Jin J., Aka J.A., Tempel W., Nguyen V., You L., Weist R.,
RA   Min J., Pawson T., Yang X.J.;
RT   "Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome
RT   protein CCDC8.";
RL   Structure 23:700-712(2015).
CC   -!- FUNCTION: May regulate the interaction between the 3M complex and the
CC       histone deacetylases HDAC4 and HDAC5 (PubMed:25752541). May also
CC       regulate LRP2/megalin (By similarity). {ECO:0000250|UniProtKB:A2ARV4,
CC       ECO:0000269|PubMed:25752541}.
CC   -!- SUBUNIT: Interacts (via ANK repeats) with CCDC8 (via PxLPxI/L motif);
CC       mediates the interaction with the 3M complex which is composed of
CC       CCDC8, CUL7 and OBSL1 (PubMed:25752541). Interacts (via ANK repeats)
CC       with HDAC4 (via PxLPxI/L motif) (PubMed:22649097). Interacts (via ANK
CC       repeats) with HDAC5 (via PxLPxI/L motif) (PubMed:22649097). Interacts
CC       (via ANK repeats) with LRP2/megalin (via PxLPxI/L motif)
CC       (PubMed:22649097). Interacts (via ANK repeats) with RFX7 (via PxLPxI/L
CC       motif) (PubMed:25752541). Interacts with AHRR (By similarity).
CC       Interacts with NEK6 (PubMed:20873783). {ECO:0000250|UniProtKB:Q99PE2,
CC       ECO:0000269|PubMed:20873783, ECO:0000269|PubMed:22649097,
CC       ECO:0000269|PubMed:25752541}.
CC   -!- INTERACTION:
CC       Q9H9E1; P56524: HDAC4; NbExp=3; IntAct=EBI-10215533, EBI-308629;
CC       Q9H9E1; Q9UPU9-3: SAMD4A; NbExp=3; IntAct=EBI-10215533, EBI-11986417;
CC       Q9H9E1; Q63HK5: TSHZ3; NbExp=3; IntAct=EBI-10215533, EBI-9053916;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q99PE2}. Membrane
CC       {ECO:0000250|UniProtKB:Q99PE2}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q99PE2}.
CC   -!- DOMAIN: The ankyrin repeats, mainly ANK 2, ANK 3 and ANK 4, mediate
CC       interaction with a wide array of PxLPxI/L motif-containing proteins
CC       including HDAC4 and LRP2. The PxLPxI/L motif of interactors can contain
CC       a Ser or a Thr residue in position 2, which phosphorylation prevents
CC       the interaction with ANKRA2. {ECO:0000269|PubMed:22649097,
CC       ECO:0000269|PubMed:25752541}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF314032; AAK01621.1; -; mRNA.
DR   EMBL; AK022876; BAB14288.1; -; mRNA.
DR   EMBL; AF251051; AAK34941.1; -; mRNA.
DR   EMBL; BC012917; AAH12917.1; -; mRNA.
DR   CCDS; CCDS4020.1; -.
DR   RefSeq; NP_075526.1; NM_023039.4.
DR   PDB; 3SO8; X-ray; 1.90 A; A=149-310.
DR   PDB; 3V2O; X-ray; 1.89 A; A=148-313.
DR   PDB; 3V2X; X-ray; 1.85 A; A=148-313.
DR   PDB; 3V31; X-ray; 1.57 A; A=148-313.
DR   PDB; 4LG6; X-ray; 1.80 A; A=142-313.
DR   PDB; 4QQI; X-ray; 2.03 A; A=142-313.
DR   PDBsum; 3SO8; -.
DR   PDBsum; 3V2O; -.
DR   PDBsum; 3V2X; -.
DR   PDBsum; 3V31; -.
DR   PDBsum; 4LG6; -.
DR   PDBsum; 4QQI; -.
DR   SMR; Q9H9E1; -.
DR   BioGRID; 121758; 34.
DR   CORUM; Q9H9E1; -.
DR   ELM; Q9H9E1; -.
DR   IntAct; Q9H9E1; 5.
DR   STRING; 9606.ENSP00000296785; -.
DR   iPTMnet; Q9H9E1; -.
DR   PhosphoSitePlus; Q9H9E1; -.
DR   BioMuta; ANKRA2; -.
DR   DMDM; 27734215; -.
DR   EPD; Q9H9E1; -.
DR   jPOST; Q9H9E1; -.
DR   MassIVE; Q9H9E1; -.
DR   MaxQB; Q9H9E1; -.
DR   PaxDb; Q9H9E1; -.
DR   PeptideAtlas; Q9H9E1; -.
DR   PRIDE; Q9H9E1; -.
DR   ProteomicsDB; 81315; -.
DR   Antibodypedia; 24269; 181 antibodies.
DR   DNASU; 57763; -.
DR   Ensembl; ENST00000296785; ENSP00000296785; ENSG00000164331.
DR   GeneID; 57763; -.
DR   KEGG; hsa:57763; -.
DR   UCSC; uc003kcu.3; human.
DR   CTD; 57763; -.
DR   DisGeNET; 57763; -.
DR   GeneCards; ANKRA2; -.
DR   HGNC; HGNC:13208; ANKRA2.
DR   HPA; ENSG00000164331; Low tissue specificity.
DR   MIM; 605787; gene.
DR   neXtProt; NX_Q9H9E1; -.
DR   OpenTargets; ENSG00000164331; -.
DR   PharmGKB; PA24803; -.
DR   VEuPathDB; HostDB:ENSG00000164331.9; -.
DR   eggNOG; KOG0502; Eukaryota.
DR   GeneTree; ENSGT00940000157156; -.
DR   HOGENOM; CLU_078123_0_0_1; -.
DR   InParanoid; Q9H9E1; -.
DR   OMA; ADPTMES; -.
DR   OrthoDB; 1348558at2759; -.
DR   PhylomeDB; Q9H9E1; -.
DR   TreeFam; TF333112; -.
DR   PathwayCommons; Q9H9E1; -.
DR   BioGRID-ORCS; 57763; 9 hits in 995 CRISPR screens.
DR   ChiTaRS; ANKRA2; human.
DR   GenomeRNAi; 57763; -.
DR   Pharos; Q9H9E1; Tbio.
DR   PRO; PR:Q9H9E1; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9H9E1; protein.
DR   Bgee; ENSG00000164331; Expressed in ectocervix and 229 other tissues.
DR   ExpressionAtlas; Q9H9E1; baseline and differential.
DR   Genevisible; Q9H9E1; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IDA:UniProtKB.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0043254; P:regulation of protein-containing complex assembly; IDA:UniProtKB.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Cytoplasm; Cytoskeleton; Membrane;
KW   Reference proteome; Repeat.
FT   CHAIN           1..313
FT                   /note="Ankyrin repeat family A protein 2"
FT                   /id="PRO_0000066895"
FT   REPEAT          148..180
FT                   /note="ANK 1"
FT   REPEAT          181..213
FT                   /note="ANK 2"
FT   REPEAT          214..246
FT                   /note="ANK 3"
FT   REPEAT          247..279
FT                   /note="ANK 4"
FT   REPEAT          280..313
FT                   /note="ANK 5"
FT   MUTAGEN         31
FT                   /note="K->R: No effect on interaction with CCDC8."
FT                   /evidence="ECO:0000269|PubMed:25752541"
FT   MUTAGEN         188
FT                   /note="W->A: Loss of interaction with CCDC8. Decreased
FT                   affinity for HDAC4."
FT                   /evidence="ECO:0000269|PubMed:22649097,
FT                   ECO:0000269|PubMed:25752541"
FT   MUTAGEN         254
FT                   /note="Y->A: Decreased affinity for HDAC4."
FT                   /evidence="ECO:0000269|PubMed:22649097"
FT   HELIX           144..147
FT                   /evidence="ECO:0007744|PDB:4QQI"
FT   HELIX           148..150
FT                   /evidence="ECO:0007744|PDB:3V2X"
FT   HELIX           153..158
FT                   /evidence="ECO:0007744|PDB:3V31"
FT   HELIX           162..171
FT                   /evidence="ECO:0007744|PDB:3V31"
FT   HELIX           185..191
FT                   /evidence="ECO:0007744|PDB:3V31"
FT   HELIX           195..203
FT                   /evidence="ECO:0007744|PDB:3V31"
FT   HELIX           218..225
FT                   /evidence="ECO:0007744|PDB:3V31"
FT   HELIX           228..237
FT                   /evidence="ECO:0007744|PDB:3V31"
FT   HELIX           251..257
FT                   /evidence="ECO:0007744|PDB:3V31"
FT   HELIX           261..269
FT                   /evidence="ECO:0007744|PDB:3V31"
FT   HELIX           284..291
FT                   /evidence="ECO:0007744|PDB:3V31"
FT   HELIX           294..307
FT                   /evidence="ECO:0007744|PDB:3V31"
SQ   SEQUENCE   313 AA;  34272 MW;  31C653B10B4ED6E1 CRC64;
     MDTSTNLDIG AQLIVEECPS TYSLTGMPDI KIEHPLDPNS EEGSAQGVAM GMKFILPNRF
     DMNVCSRFVK SLNEEDSKNI QDQVNSDLEV ASVLFKAECN IHTSPSPGIQ VRHVYTPSTT
     KHFSPIKQST TLTNKHRGNE VSTTPLLANS LSVHQLAAQG EMLYLATRIE QENVINHTDE
     EGFTPLMWAA AHGQIAVVEF LLQNGADPQL LGKGRESALS LACSKGYTDI VKMLLDCGVD
     VNEYDWNGGT PLLYAVHGNH VKCVKMLLES GADPTIETDS GYNSMDLAVA LGYRSVQQVI
     ESHLLKLLQN IKE
//
